Login / Signup

Efficacy and safety of IL-6 inhibitors in patients with COVID-19 pneumonia: a systematic review and meta-analysis of multicentre, randomized trials.

Alessandro BellettiCorrado CampochiaroMarilena MarmiereValery LikhvantsevAndrey YavorovskiyLorenzo DagnaGiovanni LandoniAlberto ZangrilloLudhmila Abrahão Hajjar
Published in: Annals of intensive care (2021)
IL-6 inhibitors reduced longest follow-up mortality and intubation in COVID-19 patients. Findings need to be confirmed in high-quality RCTs.
Keyphrases
  • sars cov
  • cardiac arrest
  • clinical trial
  • cardiovascular events
  • study protocol
  • risk factors
  • cardiovascular disease